Johnson & Johnson Stops Selling Talc-Based Baby Powder in North America
Johnson & Johnson is ending sales of its talc-based Johnson’s Baby Powder in the U.S. and Canada, after thousands of lawsuits claiming it has caused cancer.
The world’s biggest maker of health care products said Tuesday the talc-based powder will still be sold outside the U.S. and Canada.
The company said, “Demand for talc-based Johnson’s Baby Powder in North America has been declining due in large part to changes in consumer habits and fueled by misinformation around the safety of the product and a constant barrage of litigation advertising."
J&J faces about 19,400 cases alleging its talcum powder caused users to develop ovarian cancer, through use for feminine hygiene, or mesothelioma, a cancer that strikes the lungs and other organs.
Of the cases that have been tried, J&J has had 12 wins, 15 losses and seven mistrials. All of the losses have either been overturned on appeal or are still being appealed.
The company insists, and the overwhelming majority of medical research on talc indicates, that the talc baby powder is safe and doesn’t cause cancer.